期刊
LEUKEMIA
卷 28, 期 4, 页码 871-879出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2013.274
关键词
EBV; NF-kB; cell cycle; metabolism; B-cell lymphoma.
资金
- Institut National du Cancer
- Canceropole Grand-Sud-Ouest
- Comite Orientation Recherche Cancer du Limousin
- Conseil Regional du Limousin
- Comites Limousin de la Ligue contre le Cancer
- Association pour la Recherche sur le Cancer
- Societe Francaise d'Hematologie
In this study, we determined the respective roles of RelA and RelB NF-kB subunits in Epstein-Barr virus (EBV)-transformed B cells. Using different EBV-immortalized B-cell models, we showed that only RelA activation increased both survival and cell growth. RelB activity was induced secondarily to RelA activation and repressed RelA DNA binding by trapping the p50 subunit. Reciprocally, RelA activation repressed RelB activity by increasing expression of its inhibitor p100. To search for such reciprocal inhibition at the transcriptional level, we studied gene expression profiles of our RelA and RelB regulatable cellular models. Ten RelA-induced genes and one RelB-regulated gene, ARNTL2, were repressed by RelB and RelA, respectively. Apart from this gene, RelB signature was included in that of RelA Functional groups of RelA-regulated genes were for control of energy metabolism, genetic instability, protection against apoptosis, cell cycle and immune response. Additional functions coregulated by RelA and/ or RelB were autophagy and plasma cell differentiation. Altogether, these results demonstrate a cross-inhibition between RelA and RelB and suggest that, in fine, RelB was subordinated to RelA. In the view of future drug development, RelA appeared to be pivotal in both classical and alternative activation pathways, at least in EBV-transformed B cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据